These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15105135)

  • 1. Membrane sphingolipid-ergosterol interactions are important determinants of multidrug resistance in Candida albicans.
    Mukhopadhyay K; Prasad T; Saini P; Pucadyil TJ; Chattopadhyay A; Prasad R
    Antimicrob Agents Chemother; 2004 May; 48(5):1778-87. PubMed ID: 15105135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional analysis of CaIPT1, a sphingolipid biosynthetic gene involved in multidrug resistance and morphogenesis of Candida albicans.
    Prasad T; Saini P; Gaur NA; Vishwakarma RA; Khan LA; Haq QM; Prasad R
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3442-52. PubMed ID: 16048959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Membrane raft lipid constituents affect drug susceptibilities of Candida albicans.
    Pasrija R; Prasad T; Prasad R
    Biochem Soc Trans; 2005 Nov; 33(Pt 5):1219-23. PubMed ID: 16246085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug susceptibilities of yeast cells are affected by membrane lipid composition.
    Mukhopadhyay K; Kohli A; Prasad R
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3695-705. PubMed ID: 12435664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Ergosterol and Sphingolipids in the Localization and Activity of
    Urbanek AK; Muraszko J; Derkacz D; Łukaszewicz M; Bernat P; Krasowska A
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
    Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
    J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TOP2 gene disruption reduces drug susceptibility by increasing intracellular ergosterol biosynthesis in Candida albicans.
    Zheng H; Jiang YY; Wang Y; Jia XM; Yan TH; Gao PH; Yan L; Jiang LH; Ji H; Cao YB
    J Med Microbiol; 2010 Jul; 59(Pt 7):797-803. PubMed ID: 20223895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug transporters CaCdr1p and CaMdr1p of Candida albicans display different lipid specificities: both ergosterol and sphingolipids are essential for targeting of CaCdr1p to membrane rafts.
    Pasrija R; Panwar SL; Prasad R
    Antimicrob Agents Chemother; 2008 Feb; 52(2):694-704. PubMed ID: 18056285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520.
    Shukla S; Ambudkar SV; Prasad R
    J Antimicrob Chemother; 2004 Jul; 54(1):38-45. PubMed ID: 15190023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected link between iron and drug resistance of Candida spp.: iron depletion enhances membrane fluidity and drug diffusion, leading to drug-susceptible cells.
    Prasad T; Chandra A; Mukhopadhyay CK; Prasad R
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3597-606. PubMed ID: 16954314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphogenic regulator EFG1 affects the drug susceptibilities of pathogenic Candida albicans.
    Prasad T; Hameed S; Manoharlal R; Biswas S; Mukhopadhyay CK; Goswami SK; Prasad R
    FEMS Yeast Res; 2010 Aug; 10(5):587-96. PubMed ID: 20491944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria influence CDR1 efflux pump activity, Hog1-mediated oxidative stress pathway, iron homeostasis, and ergosterol levels in Candida albicans.
    Thomas E; Roman E; Claypool S; Manzoor N; Pla J; Panwar SL
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5580-99. PubMed ID: 23979757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic activity of magnolol with azoles and its possible antifungal mechanism against Candida albicans.
    Sun LM; Liao K; Liang S; Yu PH; Wang DY
    J Appl Microbiol; 2015 Apr; 118(4):826-38. PubMed ID: 25641229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lactate Like Fluconazole Reduces Ergosterol Content in the Plasma Membrane and Synergistically Kills
    Suchodolski J; Muraszko J; Bernat P; Krasowska A
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069257
    [No Abstract]   [Full Text] [Related]  

  • 15. Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans.
    Pasrija R; Krishnamurthy S; Prasad T; Ernst JF; Prasad R
    J Antimicrob Chemother; 2005 Jun; 55(6):905-13. PubMed ID: 15845783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement for Ergosterol in Berberine Tolerance Underlies Synergism of Fluconazole and Berberine against Fluconazole-Resistant
    Xu Y; Quan H; Wang Y; Zhong H; Sun J; Xu J; Jia N; Jiang Y
    Front Cell Infect Microbiol; 2017; 7():491. PubMed ID: 29238700
    [No Abstract]   [Full Text] [Related]  

  • 17. Histone deacetylase inhibitors enhance Candida albicans sensitivity to azoles and related antifungals: correlation with reduction in CDR and ERG upregulation.
    Smith WL; Edlind TD
    Antimicrob Agents Chemother; 2002 Nov; 46(11):3532-9. PubMed ID: 12384361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Membrane fluidity affects functions of Cdr1p, a multidrug ABC transporter of Candida albicans.
    Smriti ; Krishnamurthy SS; Prasad R
    FEMS Microbiol Lett; 1999 Apr; 173(2):475-81. PubMed ID: 10227177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergosterol biosynthesis inhibitors become fungicidal when combined with calcineurin inhibitors against Candida albicans, Candida glabrata, and Candida krusei.
    Onyewu C; Blankenship JR; Del Poeta M; Heitman J
    Antimicrob Agents Chemother; 2003 Mar; 47(3):956-64. PubMed ID: 12604527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K; Niimi M; Niimi K; Holmes AR; Yates JE; Decottignies A; Monk BC; Goffeau A; Cannon RD
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3366-74. PubMed ID: 11709310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.